Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M
What can be expected from the Needle-Free Delivery Technologies Market? Which areas are going to grow at the fastest rates? This Visiongain report shows you potential revenues to 2026, assessing data, trends, opportunities and prospects.
Our 183-page report provides 105 tables, charts, and graphs. Discover the most lucrative areas in the industry and the future market prospects. Our new study lets you assess forecasted sales across all the major regional and national Needle-Free Delivery Technology markets. You will see financial results, trends, opportunities, and revenue predictions. There is much opportunity in this fast moving market.
Forecasts from 2016-2026 and other analyses show you commercial prospects Besides revenue forecasting to 2026, our new study provides you with recent results, growth rates, and market shares. Discover qualitative analyses (including SWOT analysis) and commercial developments.
See revenue forecasts for the leading regional and national markets How will leading national and regional markets perform to 2026? Our study forecasts revenues in national markets, including: • US • EU5 (Germany, France, UK, Italy and Spain) • Japan • China • India • Rest of the World
Leading companies and potential for market growth Visiongain forecasts overall revenue for the Needle-Free Delivery Technologies Market will reach $2,093.9m in 2020. We predict high revenue growth over the forecast period, which will driven by the strong demand for improved vaccine and drug delivery methods.
Our work analyses the key companies in the market. See Visiongain’s analysis of six leading companies, including: • 3M • Antares Pharma • Beckton Dickinson and Company (BD) • Bioject Medical Technologies • PharmaJet • Zogenix
A company profile gives you the following information where available: • Discussion of a company’s activities and outlook including regional and national revenue shares • Historic revenue, analysis and discussion of company performance • Analysis of major products/services currently available on the market • Acquisitions and strategic partnerships
Discover capabilities, progress, and commercial prospects, helping you stay ahead.
What issues will affect the needle-free drug delivery industry? Our new report discusses issues and events affecting the needle-free delivery technology market. You will find discussions, including qualitative analyses: • Highly fragmented and competitive market with significant variations in different geographic regions • Changing political and regulatory landscape changing the prospects of future products and reimbursement opportunities • Future opportunities for needle-free delivery technologies
You will see discussions of technological, commercial, and economic matters, with emphasis on the competitive landscape and business outlooks.
How the Needle-Free Delivery Technology Market Forecast 2016-2026: Analysis and Forecasts for Jet Injector Technologies and Competing Technologies including Novel Needle Technology, Inhaler Technology and Microneedle Technology with an Assessment of Leading Companies including Antares, Zogenix and 3M report helps you In summary, our 183-page report gives you the following knowledge: • Revenue forecasts to 2026 for the Needle-Free Delivery Technology Market – discover the industry’s prospects, finding promising places for investments and revenues • Revenue forecasts to 2026 for two major submarkets – jet injectors and competing technologies (novel needle technology, inhaler technology and transdermal patch technology) • Revenue forecasts to 2026 for two major regional markets – EU5 and Rest of the World • Revenue forecasts to 2026 for the leading national markets – US, Germany, France, UK, Italy, Spain, Japan, China, India and Rest of the World • Assessment of leading companies – analysis of services, business operations, products, pipelines, revenue (where available) and recent mergers & acquisition activity • Discussion of what stimulates and restrains companies and the market • Prospects for established firms and those seeking to enter the market
You will find quantitative and qualitative analyses with independent predictions. You will receive information that only our report contains, staying informed with this invaluable business intelligence.
Information found nowhere else With our survey you are less likely to fall behind in knowledge or miss opportunities. See how you could benefit your research, analyses, and decisions. Also see how you can save time and receive recognition for commercial insight.
Visiongain’s study is for everybody needing commercial analyses for the needle-free drug delivery market and leading companies. You will find data, trends and predictions. Please order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
1. Report Overview 1.1 Global Needle-Free Delivery Technology Market Overview 1.2 Global Needle-Free Delivery Technology Market Segmentation 1.3 Why You Should Read This Report 1.4 How This Report Delivers 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report For? 1.7 Methodology 1.8 Frequently Asked Questions (FAQ) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2. Introduction to Needle-Free Delivery Technology 2.1 What is Needle-Free Delivery Technology? 2.1.1 Needlestick Injury 2.1.1.1 Blood-Borne Pathogens and Needlestick Injury 2.1.1.2 Accidental Needlestick Injury: A Serious Healthcare Problem 2.2 The Needle-Free Delivery Technology Market 2.2.1 Jet Injectors 2.2.1.1 Concerns about Multi-use Nozzle Jet injectors (MUNJIs) 2.2.1.2 Strengths and Weaknesses of Jet Injectors 2.2.2 Competing Needle-Free Technologies 2.2.2.1 Novel Needle Technology 2.2.2.2 Pen Needles 2.2.2.3 Microneedles 2.2.2.4 Hollow Microneedles 2.2.2.5 Solid Coated Microneedles 2.2.2.6 Solid Biodegradable Microneedles 2.2.2.7 Solid Uncoated Microneedles 2.2.2.8 Using the Right Microneedles 2.2.2.9 Inhaler Technology 2.2.2.10 Transdermal Patch Technology 2.3 Clinical Settings Where Needle-Free Delivery Technology Will Be Beneficial 2.3.1 Pain Management 2.3.1.1 Using Needle-Free Injection Devices to Administer Lidocaine 2.3.2 Vaccine Delivery: Improving Immune Response 2.3.2.1 Needle-Free Vaccine Delivery 2.3.2.2 Mass Immunisation 2.3.3 Insulin Delivery for Diabetics 2.3.4 Paediatric Injections 2.3.5 Other Uses for Needle-Free Injection Technology 2.4 Regulation of the Needle-Free Delivery Technology Market 2.4.1 The US Regulation System 2.4.1.1 Combination Products 2.4.1.2 FDA Statement Clamps Down On Delivery of Medications in Non-Approved Needle-Free Devices 2.4.2 The European Regulation System 2.4.2.1 Post Marketing Surveillance in the EU 2.5 Biopharmaceuticals 2.5.1 An Introduction to the Biological Drugs Market 2.5.2 Biologics: A Rising Drugs Market
3. Needle-Free Delivery Technology: Global Market 2016-2026 3.1 The Needle-Free Delivery Technology Market: Overview 3.2 Needle-Free Delivery Technology Market Segmentation, 2016 3.3 The Needle-Free Delivery Technology Market Forecast, 2016-2026 3.4 How Will Segmental Market Shares Change to 2026? 3.5 Needle-Free Delivery Technology: Market Trends, 2016-2026 3.6 Needle-Free Delivery Technology: Drivers and Restraints 2016-2026
4. Jet Injectors Technology Market, 2016-2026 4.1 The Jet Injectors Market Overview 4.2 Jet Injectors: Market Forecast 2016-2026 4.3 Jet Injector Devices on the Market 4.3.1 Biojector 2000 (Bioject Medical Technologies) 4.3.2 ZetaJet (Bioject Medical Technologies) 4.3.3 Vision (Antares Pharma) 4.3.4 Vibex (Antares Pharma) 4.3.5 Sumavel DosePro (Endo International) 4.3.6 Stratis (PharmaJet) 4.3.7 LectraJet (D’Antonio Consultants International) 4.3.8 AdvantaJet and GentleJet (Activa Brand Products) 4.3.9 Vitajet (Bioject Medical Technologies) 4.3.10 Med-Jet (Medical International Technologies) 4.3.11 J-Tip (National Medical Products) 4.3.12 Injex30 (Injex Pharma) 4.3.13 SQ-Pen, SQ-X and MHP-1 (Bespak) 4.3.14 E-Jet 100 (Eurojet Medical) 4.3.15 Penjet (Penjet Corporation) 4.4 Jet Injectors Development Pipeline 4.4.1 Glide SDI (Glide Pharmaceutical Technologies) 4.4.2 Zeneo (Crossject) 4.4.3 Relday (Zogenix) 4.4.4 Magnetic Injection (Massachusetts Institute of Technology) 4.4.5 Intradermal (ID) Pen (Bioject Medical Technologies) 4.4.6 Iject and Iject R (Bioject Medical Technologies) 4.4.7 Jupiter Jet (Bioject Medical Technologies)
5. Competing Needle-Free Technology Market, 2016-2026 5.1 The Competing Needle-Free Technology Overview 5.2 The Competing Technology: Market Forecast 2016-2026 5.3 How Will Segmental Market Shares Change to 2026? 5.4 Novel Needle Technology Overview 5.5 Novel Needle Technology: Market Forecast, 2016-2026 5.5.1 Leading Novel Needle Technologies 5.5.1.1 Soluvia Microinjection System (BD) 5.5.1.2 Ultra-Fine Nano 4mm Pen Needle (BD) 5.5.1.3 AutoShield Duo Pen Needle (BD) 5.5.1.4 Microstructured Transdermal Systems (3M) 5.5.1.5 ZP Patch Technology (Zosano) 5.5.2 Novel Needle Technology Development Pipeline 5.5.2.1 Microneedle Patch (Georgia Institute of Technology) 5.5.2.2 Micronjet (NanoPass) 5.5.2.3 DebioJect (Debiotech) 5.5.2.4 AdminPen (nanoBioSciences) 5.5.2.5 PKA SoftTouch (PKA SoftTouch Corp) 5.5.2.6 DrugMat and VaxMat (TheraJect) 5.5.2.7 MicroCor (Corium International) 5.5.2.8 Nanopatch (Vaxxas) 5.5.2.9 Nanotopography Enhanced Microneedle Delivery (University of California-San Francisco, Georgia Institute of Technology and Kimberly-Clark) 5.5.2.10 Memspatch and Micro-Patch (Nemaura) 5.5.2.11 Microneedle Patch for Lidocaine Delivery (National University of Singapore) 5.6 Inhaler Technology Overview 5.7 Inhaler Technology: Market Forecast, 2016-2026 5.7.1 Inhaler Products in the Asthma Market 5.7.1.1 Preventer Inhalers 5.7.1.2 Reliever Inhalers 5.7.2 Inhaler Products in the Insulin Market 5.7.3 Inhaler Products in the Vaccine Market: FluMist Quadrivalent (MedImmune) 5.7.3.1 Pipeline 5.8 Transdermal Patch Technology Overview 5.9 Transdermal Patch Technology: Market Forecast, 2016-2026 5.9.1 Selected Transdermal Patch Products 5.9.1.1 Duragesic (Fentanyl, Janssen Pharmaceuticals) 5.9.1.2 Nicoderm CQ (Nicotine, GlaxoSmithKline) 5.9.1.3 Exelon Patch (Rivastigmine, Novartis) 5.9.1.4 Zecuity (Sumatriptan, Teva) 5.9.2 Transdermal Patch Technology Development Pipeline 5.9.2.1 Electronic Transdermal Patch (Rhenovia Pharma) 5.9.2.2 Electroporation-Mediated DNA Drug Delivery (TriGrid, Ichor Medical Systems) 5.9.2.3 Ultrasonic Waveforms (U-Strip, Transdermal Specialties) 5.9.2.4 Prelude SkinPrep System (Echo Therapeutics) 5.10 Other Competing Needle-free delivery Technology in development 5.10.1 Microbubbles Injection (Shibaura Institute of Technology) 5.10.2 Laser Injection (Seoul National University) 5.10.3 Vaccine Delivery Using Micro-Shock Waves (Indian Institute of Science, Bangalore) 5.10.4 Nanotechnology Syringes (Gwangju Institute of Science and Technology, South Korea)
6. Leading National Markets 2016-2026 6.1 Global Needle-Free Delivery Technology Market: Regional Forecast 2016-2026 6.1.1 How Will Regional Market Shares Change to 2026? 6.2 The US Needle-Free Delivery Technology Market 2016-2026 6.2.1 US Needle-Free Delivery Technology Market Forecast 2016-2026 6.2.2 FDA Guideline for Combination Products 6.2.3 Needle-Free Delivery and the US Flu Vaccination Market 6.2.4 Measles Outbreak in the US 6.3 The EU5 Needle-Free Delivery Technology Market 2016-2026 6.3.1 EU5 Needle-Free Delivery Technology Market Forecast 2016-2026 6.3.2 The German Needle-Free Delivery Technology Market Forecast, 2016-2026 6.3.3 The French Needle-Free Delivery Technology Market Forecast, 2016-2026 6.3.4 The UK Needle-Free Delivery Technology Market Forecast, 2016-2026 6.3.5 The Italian Needle-Free Delivery Technology Market Forecast, 2015-2026 6.3.6 The Spanish Needle-Free Delivery Technology Market Forecast, 2016-2026 6.4 The Japanese Needle-Free Delivery Technology Market 2016-2026 6.4.1 Japanese Needle-Free Delivery Technology Market Forecast 2016-2026 6.5 The Chinese Needle-Free Delivery Technology Market 2016-2026 6.5.1 Chinese Needle-Free Delivery Technology Market Forecast 2016-2026 6.6 The Indian Needle-Free Delivery Technology Market 2016-2026 6.6.1 Indian Needle-Free Delivery Technology Market Forecast 2016-2026 6.6.2 Needles and Syringes being Reused in Indian Hospitals
7. Leading Companies in the Needle-Free Delivery Technology Market 7.1 Leading Needle-Free Delivery Technology Manufacturers in 2015 7.2 Antares Pharma: Leading the Needle-Free Injector Market 7.2.1 Antares Pharma: Needle-Free Technology Product Portfolio 7.2.2 Antares Pharma: Future Outlook 7.2.3 Antares Pharma: Products in Development 7.2.4 Settlement of Patent Infringement Case between Antares Pharma and Medac Pharma 7.3 Zogenix 7.3.1 Zogenix: Product Portfolio 7.3.2 Zogenix: Current Pipeline 7.3.3 Zogenix: Financial Overview 7.4 3M: 50 Years of Drug Delivery Technology Development 7.4.1 3M: Drug Delivery Technology Portfolio 7.4.1.1 Oral and Topical Drug Delivery 7.4.1.2 MDI for Nasal and Inhalable Drugs 7.4.1.3 Transdermal patch Technology 7.4.1.4 Microneedle Technology 7.4.2 3M: Market Outlook 7.5 Becton Dickinson and Company (BD) 7.5.1 BD: Drug Delivery Technology Portfolio 7.5.1.1 Prefillable Syringe Systems 7.5.1.2 Self-Injection Systems 7.5.1.3 Pen Needles 7.5.1.4 Safety & Shielding Systems 7.5.2 BD: Future Outlook 7.5.3 New Infusion Set with BD FlowSmart Technology Cleared by FDA 7.5.4 BD Acquired Injection Safety Firms 7.5.5 Recall of BD Needles in Hong Kong 7.6 PharmaJet 7.6.1 PharmaJet: Needle-Free Delivery Technology Product Portfolio 7.6.2 First FDA Approved Jet Injector for Flu Shot in the US 7.6.3 PharmaJet: Collaborations and Needle-Free Delivery Technology Pipeline 7.6.4 Preference for PharmaJet over Needle and Syringe 7.7 BioJect Medical Technologies 7.7.1 Bioject Medical Technologies: Needle-Free Delivery Technology Product Portfolio and Pipeline 7.7.2 Bioject Medical Technologies: Financial Overview 7.7.3 Focusing on Developing Countries
8. Qualitative Analysis of the Needle-Free Delivery Technology Market 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market 8.2 Strengths 8.2.1 Strong Growth in the Biologic Drug Market 8.2.2 Increasing Development in Transdermal Delivery 8.2.3 No Specialist Training Required and No Needlestick Injuries 8.2.4 Eliminating the Cold Chain Problem 8.3 Weaknesses 8.3.1 Healthcare Practitioners are not Familiar with Novel Delivery Systems 8.3.2 Greater Regulatory Scrutiny 8.3.3 Inefficient Manufacturing Processes 8.4 Opportunities 8.4.1 Emerging Economies Offer Significant Growth Opportunities 8.4.2 Mass Immunisation Programmes around the World 8.4.3 Increasing Global Diabetic Population 8.4.4 Shift towards Home Administration Setting 8.4.5 Extending Life Cycle of Drugs 8.5 Threats 8.5.1 Traditional Needles and Syringes are Very Cheap to Mass Produce 8.5.2 Needle and Syringes with Anti Needlestick Injury Technology 8.5.3 Limited Clinical Data 8.5.4 Medical Device Excise Tax
9. Conclusions 9.1 Current Leading Needle-Free Technology Segments 9.1.1 Notable Needle-Free Technology Companies 9.1.2 Leading Regional Markets 9.2 Global Needle-Free Technology Market Forecast 2015-2026 9.3 The Future of the Needle-Free Technology Market 9.3.1 Biosimilars are a Major Driver of the Needle-free Delivery Market 9.3.2 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market
10. Glossary
Appendix Visiongain’s Bespoke Research Service Some Associated Reports Visiongain Report Sales Order Form About Visiongain Report Evaluation Form
List of Tables Table 2.1 Classification of Jet Injectors by Method of Propulsion Table 2.2 Strengths and Weaknesses of the Jet Injector Market Table 2.3 Pen Needle Technology by Needle Length Table 2.4 Rationale for Needle-Free Vaccine Delivery Table 2.5 Examples of Needle-Free Vaccine Delivery Systems, 2016 Table 2.6 Examples of Needle-Free Insulin Delivery Systems for Diabetics, 2016 Table 2.7 FDA Guidance on Regulation of Needle-Free Injectors, 2015 Table 2.8 Top 5 Biologics by Sales ($bn), 2015 Table 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), Market Share (%) by Segment, 2015 Table 3.2 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 3.3 Needle-Free Delivery Market Segments: Market Size ($m) and Market Share (%), 2015, 2020 and 2026 Table 4.1 The Jet Injectors Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.1 The Competing Needle-Free Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.2 Market Size ($m) and Market Share (%) of Competing Needle-Free Technology Market Segments, 2015 Table 5.3 Novel Needle Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.4 Inhaler Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.5 Leading Products in the Asthma Preventer Inhaler Market, 2016 Table 5.6 Leading Products in the Asthma Reliever Inhaler Market, 2016 Table 5.7 Vaccine Inhalers Currently Under Development, 2016 Table 5.8 Transdermal Patch Technology Market: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 5.9 Transdermal Patch Products, 2016 Table 6.1 Global Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%) by Region, 2015-2026 Table 6.2 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015 Table 6.3 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026 Table 6.4 US Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.5 EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.6 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015, 2020 and 2026 Table 6.7 German Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.8 French Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.9 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%), CAGR (%), 2015-2026 Table 6.10 Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.11 Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.12 Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 6.13 Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%), CAGR (%), 2015-2026 Table 6.14 Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m), AGR (%) and CAGR (%), 2015-2026 Table 7.1 Antares Pharma: Overview, 2016 Table 7.2 Antares Pharma: 2016 Product Portfolio (Product, Drug, Partner, Indication and Territory Table 7.3 Antares Revenue from Major Customers: Revenue ($m) and Revenue Share (%), 2014 and 2015 Table 7.4 Antares Revenue by Region: Revenue ($m) and Revenue Share (%), 2014 and 2015 Table 7.5 Antares Pharma: Historical Revenue ($m), AGR (%) and CAGR (%), 2010-2015 Table 7.6 Antares Pharma: Products in Development 2016 (Product Name, Drug, Partner, Indication, Territory and Regulatory Status) Table 7.7 Zogenix: Overview, 2016 Table 7.8 Zogenix: Revenue ($m), AGR (%) and CAGR (%), 2010-2015 Table 7.9 Zogenix: Revenue ($m) by Type, 2010-2015 Table 7.10 3M: Overview, 2016 Table 7.11 3M: Health Care Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015 Table 7.12 BD: Overview, 2016 Table 7.13 BD: Drug Delivery Products by Segment, 2016 Table 7.14 BD: Historical Revenue ($bn) by Geographic Region, 2012-2015 Table 7.15 BD Medical: Historical Revenue ($bn), AGR (%) and CAGR (%), 2010-2015 Table 7.16 PharmaJet: Overview, 2016 Table 7.17 BioJect Medical Technologies: Overview, 2016 Table 7.18 Bioject Medical Technologies: Revenue ($m) by Product Line, 2010 Table 7.19 Bioject Medical Technologies: Revenue ($m), AGR (%) and CAGR (%), 2010-2015 Table 8.1 SWOT Analysis of the Needle-Free Delivery Technology Market, 2016-2026 Table 8.2 Average Price for Needle-Free Drug/Vaccine Delivery Technology, 2015
List of Figures Figure 1.1 Global Needle-Free Delivery Technology Market Segmentation Overview, 2015 Figure 2.1 Percentage (%) of Needlestick Injuries during the Timeline of Use to Disposal of a Device Figure 3.1 The Needle-Free Delivery Technology Market: Revenue ($m), AGR (%), 2015-2026 Figure 3.2 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2015 Figure 3.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020 Figure 3.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026 Figure 3.5 Needle-Free Delivery Technology: Drivers and Restraints 2016-2026 Figure 4.1 The Jet Injectors Market: Revenue ($m) and AGR (%), 2015-2026 Figure 5.1 The Competing Needle-Free Technology Market: Revenue ($m) and AGR (%), 2015-2026 Figure 5.2 Market Shares (%) of Competing Needle-Free Technology Market Segments, 2015 Figure 5.3 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2020 Figure 5.4 Market Shares (%) of Leading Needle-Free Delivery Market Segments, 2026 Figure 5.5 Novel Needle Technology Market: Revenue ($m) and AGR (%), 2015-2026 Figure 5.6 Inhaler Technology Market: Revenue ($m), AGR (%), 2015-2026 Figure 5.7 Transdermal Patch Technology Market: Revenue ($m) and AGR (%), 2015-2026 Figure 6.1 Global Needle-Free Delivery Technology Market: Market Size ($m) and Market Share (%) by Country/Region, 2015, 2020 and 2026 Figure 6.2 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2020 Figure 6.3 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2020-2026 Figure 6.4 Global Needle-Free Delivery Technology Market: CAGR (%) by Country/Region, 2015-2026 Figure 6.5 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2015 Figure 6.6 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2020 Figure 6.7 Global Needle-Free Delivery Technology Market: Market Share (%) by Country/Region, 2026 Figure 6.8 US Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026 Figure 6.9 EU5 Needle-Free Delivery Technology Market Forecast: Market Sixe ($m), AGR (%), 2015-2026 Figure 6.10 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2015 Figure 6.11 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2020 Figure 6.12 EU5 Needle-Free Delivery Technology Market: Market Shares (%) by National Market, 2026 Figure 6.13 German Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026 Figure 6.14 French Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026 Figure 6.15 UK Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026 Figure 6.16 Italian Needle-Free Delivery Technology Market Forecast: Market Size ($m) and AGR (%), 2015-2026 Figure 6.17 Spanish Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.18 Japanese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.19 Chinese Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 6.20 Indian Needle-Free Delivery Technology Market Forecast: Revenue ($m) and AGR (%), 2015-2026 Figure 7.1 Antares Revenue from Major Customers: Revenue Share (%), 2014 Figure 7.2 Antares Revenue from Major Customers: Revenue Share (%), 2015 Figure 7.3 Antares Revenue by Region: Revenue Share (%), 2014 Figure 7.4 Antares Revenue by Region: Revenue Share (%), 2015 Figure 7.5 Antares Pharma: Historical Revenue ($m) and AGR (%), 2010-2015 Figure 7.6 Zogenix: Revenue ($m) and AGR (%), 2010-2015 Figure 7.7 Zogenix: Revenue ($m) by Type, 2014 Figure 7.8 Zogenix: Revenue ($m) by Type, 2015 Figure 7.9 3M: Health Care Historical Revenue ($bn) and AGR (%), 2010-2015 Figure 7.10 BD: Historical Revenue ($bn) by Geographic Region, 2012-2015 Figure 7.11 BD Medical: Historical Revenue ($bn) and AGR (%), 2010-2015 Figure 7.12 Bioject Medical Technologies: Revenue Share (%) by Product Line, 2010 Figure 7.13 Bioject Medical Technologies: Revenue ($m), AGR (%), 2010-2014 Figure 8.1 The Transport Process for a Vaccine
3M Actavis Activa Brand Products AcuShot Adamis Aktiv-Dry Alkermes Alza Anesiva Antares Pharma Aradigm Astellas Pharma AstraZeneca BD BeadTek Berlex Labs Bespak bioCSL Bioject Medical Technologies Biomedics Boehringer Ingelheim Bristol-Myers Squibb and Somerset Pharmaceuticals Cambridge Consultants CareFusion Corporation CEA-LETI Corium International CosMed Crossject CureVac D’Antonio Consultants International Debiotech Durect Echo Therapeutics Elcam Medical Eli Lilly & Co Endo International Ethical Holdings/Schering Eurojet Medical Ferndale Georgia Institute of Technology Giant Eagle GlaxoSmithKline Glide Pharmaceutical Technologies Hangzhou Hema Medical Equipment Haselmeir GmbH Health-Mor Personal Care Hirtenberger Ichor iHealthNet Immunomic Therapeutics ImmusanT Injex Pharma Inovio Pharmaceuticals Invion Janssen Pharmaceuticals Key Pharmaceuticals Kroger LEO Pharma LTS Lohmann Therapie-Systeme MannKind Mecaplast Meda Pharmaceuticals Medac Pharma Medical International Technologies Medi-Ject MedImmune Merck Merck Serono Micron Biomedical Mylan nanoBioSciences NanoPass Napp Pharmaceuticals National Medical Products Nektar Therapeutics Nemaura Nicobrand Limited Novartis Novo Nordisk Novogyne Pharmaceuticals NuPathe Nycomed Ortho-McNeil Owen MumFord Inc Par Pharmaceutical Parke-Davis Penjet Corporation Pernix Pfizer PharmaJet PKA SoftTouch Corp Procter & Gamble ProStrakan Purdue Pharma Radius Health Rhenovia Pharma Rite Aid Roche Sandoz Sanofi Searle Pharmaceuticals Shire SHL Group AB Shwarz-Pharma Société Nationale des Poudres et Explosifs STADA Arzneimittel AG Stat Medical Devices Takeda Teva The Medical House TheraJect TheraTech Transdermal Specialties Trimeris Trinity-Chiesi UCB Pharma University of California-San Francisco Vaxxas Vetter Pharma Vyteris Watson West Pharmaceuticals Westmount Pharmacy Ypsomed AG Zogenix Zosano Zydus Cadila
Organisations Mentioned in the Report Ankara University Atlanta’s Emory University Bill & Melinda Gates Foundation Gwangju Institute of Science and Technology Indian Institute of Science, Bangalore Massachusetts Institute of Technology National University of Singapore Oxford University Seoul National University Shibaura Institute of Technology University of Texas University of Wisconsin’s Hospital
Download sample pages
Complete the form below to download your free sample pages for Needle-Free Delivery Technology Market Forecast 2016-2026
Download sample pages
Complete the form below to download your free sample pages for Needle-Free Delivery Technology Market Forecast 2016-2026
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
Win a Free Visiongain Pharma report – ‘Like’ our Pharma Facebook page with the link below and enter into our raffle to win a free, unlocked Visiongain report, choosing your relevant report from our reports selection.
Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.
Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031
Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.
Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
